Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

3.840 +0.050 (+1.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 612,096
Open 3.800
Bid (Size) 3.760 (50)
Ask (Size) 3.900 (32)
Prev. Close 3.790
Today's Range 3.580 - 3.938
52wk Range 1.380 - 19.69
Shares Outstanding 348,875,959
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025
From Agenus Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga

Performance

YTD
+24.3%
+24.3%
1 Month
+66.2%
+66.2%
3 Month
+9.1%
+9.1%
6 Month
+46.0%
+46.0%
1 Year
-64.1%
-64.1%

More News

Read More
Agenus Reports Q1 2025 Financial Results and Key Business Updates
From Agenus Inc.
Via Business Wire
Earnings Scheduled For May 12, 2025
Via Benzinga
Agenus's Earnings: A Preview
Via Benzinga
Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer
From Agenus Inc.
Via Business Wire
Agenus to Provide Corporate Update and First Quarter 2025 Financial Report
From Agenus Inc.
Via Business Wire
Agenus’ BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR
From Agenus Inc.
Via Business Wire
Agenus’ BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025
From Agenus Inc.
Via Business Wire
Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025
From Agenus Inc.
Via Business Wire
Here are the top movers in Tuesday's session.
Via Chartmill
Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
From Agenus Inc.
Via Business Wire
Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation
From Agenus Inc.
Via Business Wire
Agenus (AGEN) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program
From Agenus Inc.
Via Business Wire
Earnings Scheduled For March 11, 2025
Via Benzinga
Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications
From Agenus Inc.
Via Business Wire
Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference
From Agenus Inc.
Via Business Wire
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report
From Agenus Inc.
Via Business Wire
Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting
From Agenus Inc.
Via Business Wire
CORRECTING and REPLACING Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting
From Agenus Inc.
Via Business Wire
Agenus Announces Publication in the Journal of Clinical Oncology Highlighting Data from Botensilimab Plus Balstilimab in Relapsed/Refractory Metastatic Sarcomas
From Agenus Inc.
Via Business Wire
Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease
From Agenus Inc.
Via Business Wire
Agenus Announces Five Presentations at ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers
From Agenus Inc.
Via Business Wire
Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs
From Agenus Inc.
Via Business Wire

Frequently Asked Questions

Is Agenus Inc. - Common Stock publicly traded?
Yes, Agenus Inc. - Common Stock is publicly traded.
What exchange does Agenus Inc. - Common Stock trade on?
Agenus Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Agenus Inc. - Common Stock?
The ticker symbol for Agenus Inc. - Common Stock is AGEN on the Nasdaq Stock Market
What is the current price of Agenus Inc. - Common Stock?
The current price of Agenus Inc. - Common Stock is 3.840
When was Agenus Inc. - Common Stock last traded?
The last trade of Agenus Inc. - Common Stock was at 05/20/25 04:00 PM ET
What is the market capitalization of Agenus Inc. - Common Stock?
The market capitalization of Agenus Inc. - Common Stock is 1.34B
How many shares of Agenus Inc. - Common Stock are outstanding?
Agenus Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.